PaxMedica Statistics
Total Valuation
PaxMedica has a market cap or net worth of 630,334. The enterprise value is 305,854.
| Market Cap | 630,334 |
| Enterprise Value | 305,854 |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PaxMedica has 126.07 million shares outstanding.
| Current Share Class | 126.07M |
| Shares Outstanding | 126.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.20% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 0.49% |
| Float | 125.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38
| Current Ratio | 0.38 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11,794.75 |
Financial Efficiency
Return on equity (ROE) is -7,716.49% and return on invested capital (ROIC) is -909.14%.
| Return on Equity (ROE) | -7,716.49% |
| Return on Assets (ROA) | -324.69% |
| Return on Invested Capital (ROIC) | -909.14% |
| Return on Capital Employed (ROCE) | 1,180.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.52M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.19% in the last 52 weeks. The beta is -47.09, so PaxMedica's price volatility has been lower than the market average.
| Beta (5Y) | -47.09 |
| 52-Week Price Change | -95.19% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 99.67 |
| Average Volume (20 Days) | 19,088 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.44M |
| Pretax Income | -17.66M |
| Net Income | -17.66M |
| EBITDA | n/a |
| EBIT | -15.44M |
| Earnings Per Share (EPS) | -3.51 |
Balance Sheet
The company has 324,486 in cash and n/a in debt, giving a net cash position of 324,486 or 0.00 per share.
| Cash & Cash Equivalents | 324,486 |
| Total Debt | n/a |
| Net Cash | 324,486 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -1.81M |
| Book Value Per Share | -0.23 |
| Working Capital | -1.31M |
Cash Flow
| Operating Cash Flow | -9.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PaxMedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -606.41% |
| Shareholder Yield | -606.41% |
| Earnings Yield | -2,801.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 2023. It was a reverse split with a ratio of 0.0588235.
| Last Split Date | Oct 31, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0588235 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |